Investing in Aclaris Therapeutics, Inc. (ACRS)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)1.8049
Intrinsic value (DCF)2.2788
Graham-Dodd Method0.00-100
Graham Formula50.454070

Company description

Aclaris Therapeutics (ticker: ACRS) is a biopharmaceutical company that is dedicated to developing and commercializing innovative treatments for dermatological and immunological conditions. Founded in 2012, Aclaris has rapidly become a leader in the field of dermatology, with a strong focus on addressing unmet needs in the market. The company utilizes cutting-edge research and advanced technology to develop differentiated products that offer significant improvements over existing treatment options. Their pipeline includes potential treatments for various conditions, such as alopecia, vitiligo, and rheumatoid arthritis. Additionally, Aclaris has a track record of successful partnerships and collaborations with other pharmaceutical companies to further advance their research and development efforts. With a highly experienced team and a strong commitment to delivering meaningful therapies, Aclaris is poised for continued growth and success in the ever-evolving healthcare industry. Overall, Aclaris Therapeutics is a dynamic and innovative company that is constantly pushing the boundaries to improve the lives of patients suffering from dermatological and immunological conditions.